Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | NR3C2 | P08235 | 6/20 | 0.33 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7966147 | 0.82 | MAPT (0.32) | NPSR1NR3C2MAPT | |
| SCHEMBL7965147 | 0.76 | CYP11B1 (0.31) | — | |
| SCHEMBL7968012 | 0.74 | TP53 (0.42) | ALDH1A1KMT2ASMN1; SMN2NPSR1NR3C2 | |
| SCHEMBL9599303 | 0.72 | NR3C2 (0.38) | ALDH1A1KMT2ASMN1; SMN2NPSR1NR3C2 | |
| SCHEMBL7964572 | 0.68 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL6849141 | 0.68 | — | — | |
| SCHEMBL11716549 | 0.67 | GRM7 (0.34) | — | |
| SCHEMBL4105175 | 0.64 | NR3C2 (0.44) | ALDH1A1KMT2ASMN1; SMN2NPSR1NR3C2 | |
| SCHEMBL7967889 | 0.64 | — | — | |
| SCHEMBL10911239 | 0.63 | MMP12 (0.36) | ALDH1A1KMT2ASMN1; SMN2NPSR1NR3C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6294503-B1 | HERBICIDAL COMPOSITIONS CONTAINING HETEROCYCLES | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2001-09-25 | — | — | US | disclosed |